Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of initial low-dose amlodipine combination therapy in Chinese patients with hypertension and cardiovascular risk factors
ChiCTR-TRC-08000087Phase 4Completed
- Sponsor
- Fuwai Hospital
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amlodipine, telmisartan, amiloride and simvastatin in hypertension (HTN) (6 arms), sponsored by Fuwai Hospital. Primary endpoint: Incidence rate of composite cardiovascular events. Started Oct 2007; status: completed.
02
Drugs
amlodipinetelmisartanamiloridesimvastatin
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR-TRC-08000087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000087.